| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281768 | Clinical Gastroenterology and Hepatology | 2014 | 10 Pages |
Abstract
Patients with IBD, particularly CD, are at increased risk for gastrointestinal and extraintestinal malignancies. The relative risk of gastrointestinal malignancy has decreased since 1978, without a concomitant increase in the risk of nongastrointestinal malignancy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Michael D. Kappelman, Dora K. Farkas, Millie D. Long, Rune Erichsen, Robert S. Sandler, Henrik T. Sørensen, John A. Baron,